Week 11 - GU Flashcards
Upper UTI
Kidney & ureter infection
Lower UTI
- Urinary bladder, prostate. Urethra
- Non-specific = lower - bladder infection
Pyelonephritis
- Infection of renal pelvis - urine drains into ureters & carried to bladder
- More rare, higher up
UTI Risk Populations
- Children & elderly
- Women - pregnancy, menopause, sexual intercourse
E. Coli
- Common causative agent of urinary system infection
- Facultative anaerobic
- Bacterial pathogen
- Found in lower intestine
UTI Impairments
- Disrupt normal washout of agent from urinary tract through flow
- Change to protective properties of mucin lining
- Disrupt protective function of normal bacterial flora
UTI Infectious Process
- Bacteria enter through urethra with aid of pili
- Colonize in bladder
Pyelonephritis Infectious Process
Infection can ascend from urinary tract to upper region
UTI Test Markers
- Positive leukocytes
- Positive blood
- Occasionally protein
- Positive nitrites - E.coli
UTI Testing
- Sterile sample of midstream urine
- Urine dipstick - point of care test
- C&S
BV Causes
- Multiple sex partners
- New sex partner
- Vaginal douching
- Lack of vaginal lactobacilli
BV Infectious Process
- Shift of vaginal flora
- Reduced numbers of lactobacillus species
- Overgrowth of Gardnerella vaginalis & some other anaerobes
Overgrowth of Vaginal Anaerobes
- Increase conversion of vaginal peptides to variety of amines - high pH
- Become volatile & malodorous
Elevated pH Conditions
- Gardnerella vaginalis adhere to exfoliating epithelial cells of vaginal mucosa
- Create clue cells
- Epithelial cells covered with masses of coccobacilli
Candidiasis (Yeast Infections)
- Common cause of vulvovaginitis
- Candida albicans common organism
- Not considered STI
- Can be passed between partners
Yeast Infection Diagnosis
- Vaginal culture
- Show budding yeast filaments (hyphae) & spores
Epididymitis
- Inflammation of epididymis
- Can be associated with gonorrhea & chlamydia
- Gram negative rods (e.coli)
Epididymitis Infectious Process
- Pressure associated with voiding/physical strain fore pathogen urine up
- Urine goes up ejaculatory duct into epididymis
- Pre-pubertal - associated with congenital urinary tract abnormality
Epididymitis Testing
- Urinalysis
- Urine culture
- Urethral swabs
Orchitis
- Infection of testes
- Precipitated by primary GU tract infection
- Spread to testes via bloodstream/lymphatic
- Caused by mumps virus
Protatitis
- Variety of inflammatory disorders of prostate gland - some bacterial
- Catheterization, instrumentation, secondary to other GU diseases
Acute Bacterial Prostatitis
- Subtype of UTI
- Ascending urethral infection, reflux of infected urine into prostatic ducts
- Commonly e.coli
Balanitis
- Fungal origin
- Common in uncircumcised males
Retroviridae Family
- Latency
- Persistent viremia
- Infection of nervous system
- Weakened host immune responses
- Destroys CD4 T-lymphocytes
HIV Composition
- Two layers of lipids
- Protein spikes embedded in envelope to enter hosts
- High affinity for CD4 lymphocytes & monocytes
- Bind to CD4 cells & becomes internalized
HIV Binding
- HIV attacks CD4 cell
- Binds to CD4 receptor then to CCR5 or CXCR4 co-receptor
- Must bind both sites to enter cell
CD4 Co-Receptors
- Protein on cell surface
- Serves as second binding site for virus/other molecule
HIV Fusion
- Viral envelope fuses with CD4 cell membrane
- Allows HIV to enter CD4 cells
- Release RNA & enzymes (transcriptase & integrase) - once inside
HIV Reverse Transcription
- Uses reverse transcriptase to convert its genetic material
- HIV RNA into HIV DNA
- Allows HIV to enter CD4 cell nucleus & combine with cell’s genetic material
HIV Integration
- Release integrase
- Used to insert/integrate viral DNA into the host DNA
HIV Replication
- Once integrated into host CD4 cell DNA
- Virus uses CD4 machinery to create long chains of HIV proteins
- Building blocks for more DNA
HIV Assembly
- New HIV RNA & proteins are made by host CD4 cell
- Move to cell surface
- Assemble into immature non-infectious DNA
HIV Budding
- Immature non-infectious HIV pushes out of host cell
- Outside CD4 cell new HIV release protease
- Protease breaks up long protein chains forming the non-infectious virus
- Smaller HIV proteins combine to form mature infectious HIV
HIV Transmission
- Direct contact with virus
- Infected bodily fluids - semen/vaginal
- Mother to child during pregnancy, labor & delivery, breastfeeding
Acute HIV
- Rapid multiplication of virus
- Progress to chronic infection
- Multiplies less rapidly & levels tend to drop
- Extends 2-4wks until body produces enough detectable antibodies
Chronic HIV
- As infection advances HIV levels increase
- Number of CD4 cells decrease - immune system damage
- Antiretroviral therapy can help prevent advancement to AIDS
Viral Latency
- Chronic HIV infection
- Virus present in body but exists without producing more virus
- Doesn’t cause noticeable symptoms - can remain in this state for long time
- Can be a highly transmissible time for those unaware
AIDS CD4 Count
Less than 200
AIDS Clinical Manifestations
- Opportunistic infections - protozoal, fungal, bacterial, viral
- Malignancies
- Dementia type complex
HIV Testing
- Point-of-care - finger prick
- If POC test positive confirmatory testing done with blood vial
- Self-test - antibody levels
- Genus HIV1/2 confirmatory assay - standard test confirm reactive HIV antibody
- Positive = look for p24 antigen
P24 Antigen
- Major protein contained in HIV viral core
- Most likely used to detect virus’s genetic material
HIV Window Period
- Time between exposure and when test can detect virus
- 2wks-3mth
- Once markers are in detectable amount window period over
- Suspect exposure come back 4-12wks for repeat test
Viral Load
- Amount of HIV in a sample of blood
- Reported as number of HIV copies per mL of blood
- Higher viral load = more damage to immune system
CD4 Count
- Measures number of CD4 T lymphocytes in blood sample
- Most important indicator of immune function
- Strongest predictor of HIV progression
- Monitor response to antiretroviral therapy
- Want count to be as high as possible
HIV Mutation
- Exhibits frequent antigenic variations
- Error-prone nature of reverse transcriptase
- Medication non-compliance can contribute to mutation
Syphilis Risk Factors
- Sex between men
- HIV (men or women)
- Younger than 29
- History of incarceration
- Methamphetamine use
- Injection drug use
- Exchanging sex for money/drugs
Syphilis Structure
- Etiologic agent T. pallidum
- Spirochete class
- Corkscrew shaped
- Motile microaerophilic bacterium
- Cannot be view by normal light microscopy
Primary Syphilis
- Proliferate, sensitize lymphocytes, activate macrophages
- Formation of primary lesion at inoculation site
- Chancre appears 2-3wks after acquisition
- Highly infections
- Heal spontaneously 3-8wks
Secondary Syphilis
- Hematogenous dissemination
- 4-10wks after onset of primary chancre
Latent Syphilis
- Persistence of T. pallidum organisms in body without symptoms
- Classified into early & late
- Early = less than 1 year
Tertiary Syphilis
- Rare due to antibiotic availability, screening, early treatment
- Without treatment 50% progress in 2-50years
Neurosyphilis
- Invasion of CNS - can occur at any stage
- Tends to form after multiple years/decades
- CSF abnormalities scan occur
- Meningeal syphilis common manifestation - weeks to moths after initial infection
Congenital Syphilis
- Transmitted from pregnant women to fetus
- Less often occurrence at time of delivery
- Primary & secondary stages
- 3rd trimester
Syphilis Enzyme Immunoassay EIA
- Treponemal test
- Measures IgM & IgG abs for T. pallidum
- Once test is positive, will stay positive for life
Rapid Plasma Reagin RPR
- Non treponemal test
- Measures antibody titres - correlate with disease activity
- Indicator of response to therapy - fall in titers over time
Syphilis Treatment
- Penicillin G - parenteral admin, all stages
- Doxycycline oral used for penicillin allergy
STI Complication
- Fertility
- Gynecological issues
- Pelvic inflammatory disease - abscesses & scaring of vagina, uterus, ovaries
- Pelvic pain - painful periods
- Ectopic pregnancies
Chlamydia
- Obligate intracellular pathogen
- Lack of symptoms present
Chlamydia Process
Bacteria enters through tiny breaks in perigenital skin/mucous membranes
Gonorrhea
- Diplococcus
- Virulent strains have pili for attachment
- Outer membrane & lipids - escape phagocytosis
- Produces endotoxin
Gonorrhoea Infection
Same time as chlamydia - treat both at same time
Trichomoniasis
- Flagellated protozoa
- Considered STI
- Not a reportable disease to public health
- Predisposing factor: multiple partners
- Men often asymptomatic
Pregnancy & Trichomoniasis
- Premature rupture of membranes
- Preterm birth
- Low birth weight
Condylomata Acuminata (Genital Warts)
- Caused by HPV
- HPV infection can occur with any skin-to-skin contact
- Often asymptomatic, transient, resolve without treatment
HPV
- Non-enveloped
- Double stranded DNA virus
- Cause proliferative lesions of squamous epithelium
- Subtypes based on likelihood of inducing dysplasia/carcinoma
HPV Subtypes 6 & 11
Considered low risk - found in most external genital warts
HPV Subtypes 16 & 18
High risk - cervical dysplasia & anogenital cancers
Genital Warts
- Soft, raised
- Fleshy lesion on external genitalia
- Can be flat, rough-surface, pedunculated
Genital Warts Timeline
- Incubation 6wks-8mths for genital warts
- Immune system clear virus in most people over 2y
Molluscum Contagiosum
- Viral disease of skin - gives rise to multiple umbilicated papules
- Mildly contagious
- Dom-like lesions, dimpled appearance
- Benign, self-limiting infection
- Spontaneously regress over 6mth-1y
Molluscum Contagiosum Transmission
- Skin-to-skin contact
- Fomites
- Auto-inoculation
Human Monkeypox MPOX
- Not an STI
- Symptoms similar to smallpox patients - clinically less severe
- Enveloped
- Double strand DNA
- Clade I & II - I most prominent
MPOX Transmission
- Animal hosts: rodents & non-human primates
- Close contact with respiratory secretions - prolonged face to face contact
- Skin lesions of infected person
- Recently contaminated object
- Pregnant women to unborn baby
MPOX Risk Factors
- Men who have sex with men
- Preexisting HIV
MPOX Timeline
- Invasion period 0-5 days
- Skin eruption begins 1-3 days after fever starts
- Incubation 6-13 days up to 21 days
- Symptoms last 2-4wks - longer with weakened immune system
MPOX Testing
- Detection of viral DNA by PCR testing
- Diagnostic specimen taken directly from rash
- Deroofing 1 of the lesions
Imvamune Vaccine
- Live attenuated
- 2 doses, 28 days apart
- Given within 4 days of contact with MPOX - up to 14 days if no symptoms develop
Gonorrhea & Chlamydia Testing
- Urine first catch
- NAATs detect presence of infection DNA
HIV, Hep, Syphilis Testing
- Antigen detection
- Blood test
HPV Testing
- No specific testing recommended to verify presence/type of warts
- DNA/RNA tests to detect genotypes
HSV Testing
- Fluid for culture/NAAT detection - swab lesion
- Scrape base of lesion for ulcers
- Active lesions must be present to test
Not Curable
- HSV
- HIV/AIDS
- Hep B
Urine Dip Analysis
- Glucose
- Protein ‘blood
- Nitrites
- Leukocytes
- pH
- Non-sterile urine sample
Urine C&S
- Growing bacteria from urine sample
- Determine which antibiotics can treat identified bacteria
- Takes 24-48h
- Sterile urine sample
Nucleic Acid Amplification Tests (NAATs)
- Amplify specific segments of genetic material (DNA/RNA)
- PCR to replicate target genetic material
- Copies of target make it easier to detect
Wet Mount Microscopy
Visually identify trichomonas parasite
Syphilis Testing
- Blood test
- Antibodies produced in response to bacteria
- Treponemal antibody test -most common
- If positive 2nd test done (non-treponemal test)
- Can identify current & past infections
Herpes Testing
- Blood test & viral culture/PCR
- Type specific herpes antibody test